Kathy  Ordonez net worth and biography

Kathy Ordonez Biography and Net Worth

Kathy Ordoñez brings more than 30 years of experience in the life sciences and diagnostics industries. From January 2012 until June 2013, Ms. Ordoñez was a Senior Vice President at Quest Diagnostics Inc., a leading provider of diagnostic information services, where she was initially responsible for leading the company’s R&D effort and later provided oversight to multiple businesses commercializing diagnostic products and testing services. She joined Quest Diagnostics as part of its acquisition of Celera Corporation, a leading provider of genetic testing products for HIV resistance, Cystic Fibrosis and high complexity tissue transplantation, in 2011. From April 2002 until May 2011, Ms. Ordoñez was the Chief Executive Officer at Celera and she founded Celera Diagnostics in December 2000. From 1985 until 2000, Ms. Ordoñez held several senior positions at Hoffmann- La Roche, overseeing the formation of Roche Molecular Systems, where she served as President and Chief Executive Officer, and led the wide-scale commercial application of the Polymerase Chain Reaction (PCR) technology to the research, diagnostic and forensic fields. Ms. Ordoñez also served as Director, non-Executive Chairman, and Chief Executive Officer of RainDance Technologies, Inc., which was sold to Bio-Rad Laboratories, Inc. in February 2017. In mid-2019, Ms. Ordoñez joined the Quidel Corporation Board of Directors.

What is Kathy Ordonez's net worth?

The estimated net worth of Kathy Ordonez is at least $352,385.28 as of February 16th, 2021. Ms. Ordonez owns 91,767 shares of Pacific Biosciences of California stock worth more than $352,385 as of March 28th. This net worth evaluation does not reflect any other investments that Ms. Ordonez may own. Learn More about Kathy Ordonez's net worth.

How do I contact Kathy Ordonez?

The corporate mailing address for Ms. Ordonez and other Pacific Biosciences of California executives is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. Pacific Biosciences of California can also be reached via phone at (650) 521-8000 and via email at [email protected]. Learn More on Kathy Ordonez's contact information.

Has Kathy Ordonez been buying or selling shares of Pacific Biosciences of California?

Kathy Ordonez has not been actively trading shares of Pacific Biosciences of California during the last quarter. Most recently, Kathy Ordonez sold 3,280 shares of the business's stock in a transaction on Wednesday, February 16th. The shares were sold at an average price of $11.50, for a transaction totalling $37,720.00. Learn More on Kathy Ordonez's trading history.

Who are Pacific Biosciences of California's active insiders?

Pacific Biosciences of California's insider roster includes (Pres), William Ericson (Director), Peter Fromen (Insider), Susan Kim (CFO), Kathy Ordonez (Director), and Mark Van Oene (COO). Learn More on Pacific Biosciences of California's active insiders.

Are insiders buying or selling shares of Pacific Biosciences of California?

During the last year, Pacific Biosciences of California insiders bought shares 1 times. They purchased a total of 40,000 shares worth more than $176,000.00. During the last year, insiders at the biotechnology company sold shares 9 times. They sold a total of 219,637 shares worth more than $1,971,923.77. The most recent insider tranaction occured on March, 6th when Director David W Meline bought 40,000 shares worth more than $176,000.00. Insiders at Pacific Biosciences of California own 1.9% of the company. Learn More about insider trades at Pacific Biosciences of California.

Information on this page was last updated on 3/6/2024.

Kathy Ordonez Insider Trading History at Pacific Biosciences of California

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/16/2022Sell3,280$11.50$37,720.00View SEC Filing Icon  
2/16/2021Sell220,771$47.99$10,594,800.2991,767View SEC Filing Icon  
2/19/2019Sell6,933$7.17$49,709.6163,700View SEC Filing Icon  
11/27/2018Sell25,000$7.54$188,500.0068,750View SEC Filing Icon  
See Full Table

Kathy Ordonez Buying and Selling Activity at Pacific Biosciences of California

This chart shows Kathy Ordonez's buying and selling at Pacific Biosciences of California by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pacific Biosciences of California Company Overview

Pacific Biosciences of California logo
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Read More

Today's Range

Now: $3.75
Low: $3.68
High: $3.89

50 Day Range

MA: $5.45
Low: $3.52
High: $7.40

2 Week Range

Now: $3.75
Low: $3.45
High: $14.55

Volume

6,560,447 shs

Average Volume

8,815,038 shs

Market Capitalization

$1.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.87